Symbol
| PDYN
| contributors: mct - updated : 30-03-2017
|
HGNC name
| prodynorphin
|
HGNC id
| 8820
|
corresponding disease(s)
|
SCA23
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
occurring during aging and AD may mediate cognitive deficits by altering the glutamatergic system integrity | constitutional
|  
|  
| --low
|  
|
in frontotemporal dementia (FTD) | |
Susceptibility
|
to alcohol dependence to opioid addiction to develop Temporal Lobe Epilepsy (TLE) in subjects with familial predisposition |
Variant & Polymorphism
repeat
, other
| allelic variation at the promoter contributing to prtection against cocaine dependence |
|
polymorphisms increasing alcohol dependence |
|
functional allelic variants in the PDYN promoter might modify the risk to develop Temporal Lobe Epilepsy (TLE) in subjects with familial predisposition |
|
polymorphisms in PDYN are associated with opioid addiction |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
miscelleaneous | pain | | |
mechanism for endogenous dynorphin to promote pain through its agonist action at bradykinin receptors and suggest new avenues for therapeutic intervention |
| | | |